BioTissue Ocular

BioTissue Ocular We develop innovative Amniotic Membrane products for the management of ocular surface diseases.

BioTissue® is the leader in regenerative biologic therapies and ocular hygiene solutions, helping eye care professionals heal ocular surface conditions, such as keratitis, recurrent corneal erosions, conjunctivochalasis dry eye, pterygium and dry eye.

On Thanksgiving, we’re reflecting on what truly matters. 🌟 The passion of our people, who bring innovation and care to...
11/27/2025

On Thanksgiving, we’re reflecting on what truly matters.

🌟 The passion of our people, who bring innovation and care to life

👩‍⚕️👨‍⚕️ The trust from providers who choose us to support their patients

💙 The opportunity to make a lasting impact on eye care & beyond

Wishing you a holiday filled with gratitude and joy!

Every breakthrough begins with people willing to challenge the standard of care. At our BioTissue Ocular Summit 2025 in ...
11/20/2025

Every breakthrough begins with people willing to challenge the standard of care.
At our BioTissue Ocular Summit 2025 in Dallas, you — our attendees—brought the ideas, the collaboration, and the momentum that push eye care forward.
We’re honored to keep building with you.

11/19/2025

Your patients have questions. We’ve got answers & resources!

Quick guides, FAQs, and easy-to-follow instructions are just a click away.

👉 https://brnw.ch/21wXE2d

11/14/2025

It’s not just for Dry Eye Disease...CAM360 AmnioGraftᵀᴹ helps you intervene earlier across multiple ocular surface challenges, from mild to moderate Dry Eye to Stage 1 NK.

11/13/2025

💡Not all Amniotic Membranes are processed the same.
Cryopreservation process maintains the innate biological properties, like anti-inflammatory and anti-scarring properties.¹,³

Why settle for less?

1.Cooke, M, Tan, EK, Mandrycky, C. et al.. Comparison of cryopreserved amniotic membrane and umbilical cord tissue with dehydrated amniotic membrane/chorion tissue. J Wound Care. 2014 Oct;23(10):465-74, 476. doi: 10.12968/jowc.2014.23.10.465. PMID: 25296347.

2. Zhang, Y, Helman, A, Mead, O. et al. Processing Methods Affect Biological Properties of Amniotic Membrane Sheet Products. Cornea. 2025;44(6):671-678, June 2025. //DOI: 10.1097/ICO.0000000000003849.

3. Data on file.

11/07/2025

👀 Think NK is “rare?” Think again.
31.4% of Dry Eye patients have been shown to have underlying Neurotrophic Keratitis.¹

Corneal Sensitivity Testing can help you identify NK patients earlier on in your patients.

Don’t let hidden symptoms slip under the radar.



1. Stolz M. The Prevalence of Corneal Sensitivity Loss in Patients with and without Dry Eye Disease. Clin Ophthalmol. 2025 Apr 18;19:1323-1330.

10/30/2025

You didn’t hear it from us… oh wait, yes you did. 👀

At ASOPRS 2025, we hosted a fantastic dinner with Dr. Alon Kahana, who shared his experience using AmnioGuard® in Oculop...
10/24/2025

At ASOPRS 2025, we hosted a fantastic dinner with Dr. Alon Kahana, who shared his experience using AmnioGuard® in Oculoplastics.

We got to connect with surgeons about improving outcomes with AmnioGuard and AmnioGraft®.

Thank you to everyone who joined us!

If you’ve talked to us at AAO, you already know the punchline: early intervention matters. And if you’re not tired of he...
10/22/2025

If you’ve talked to us at AAO, you already know the punchline: early intervention matters.

And if you’re not tired of hearing it yet… we’ll say it louder for the people in the back!!


CAM360 AmnioGraft™ & Prokera® can help you intervene earlier with your patients.

Missed us? Check out our website to speak with our team!

10/21/2025

Eye drops not working like you would have hoped?

Still experiencing dry, irritated eyes that never seem to get better?
Preliminary data has shown CAM360 AmnioGraftTM helped promote improvements in both signs and symptoms within 2 to 3- days in patients with mild to moderate DED..1

Ask your physician if it’s right for you.


1. Short-Term Outcomes Associated with CAM360 AmnioGraft™: Results from Real-World Evidence. BioTissue® Holdings Inc.; 2025. US-CAM360-0110.

👀Look out for us at AAO! Here’s a sneak peek of the BioTissue Booth #3109 that you’ll see next week in Orlando. Time m...
10/15/2025

👀Look out for us at AAO!
Here’s a sneak peek of the BioTissue Booth #3109 that you’ll see next week in Orlando.

Time matters. Don’t wait until “next year’s AAO” to start the conversation. Stop by and let’s talk early intervention with Cryopreserved Amniotic Membranes.

Poster:
Effect of Cryopreserved Amniotic Membrane after Corneal Cross-Linking in Keratoconus Patients: A Controlled, Retrospective Study – Melanne Rosetta, OD & Reena Gupta, MD

Address

7300 Corporate Center Drive, Suite 700
Miami, FL
33126

Website

Alerts

Be the first to know and let us send you an email when BioTissue Ocular posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category